Jason Haas - Insider Trading & Ownership

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge, MA
Summary
The estimated net worth of Jason Haas is at least $813K dollars as of September 12, 2024. Jason Haas is the Director of LIGAND PHARMACEUTICALS INC and owns shares of LIGAND PHARMACEUTICALS INC (LGND) stock worth about $468K. Jason Haas is the Chief Financial Officer of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. (SYRS) stock worth about $345K.
All Insider Reports
All Insider Reports

Ownership of Jason Haas

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LGND, LGNDZ LIGAND PHARMACEUTICALS INC Director $468K Jun 14, 2024
SYRS Syros Pharmaceuticals, Inc. Chief Financial Officer $345K +$161K +87.6% Sep 10, 2024

Insider Transactions Reported by Jason Haas:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.